J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

When we examine it carefully, culture can reveal the hidden barriers between current performance and desired success.

Providing compassionate care isn't just a choice that health care workers make; it requires larger systems and leaders to ...